Your outpatient has COVID-19: what are their treatment options in the current SARS-CoV-2 variant climate?
Description
Mutations accumulated by novel SARS-CoV-2 Omicron sublineages contribute to evasion of previously effective monoclonal antibodies for treatment or prevention of COVID-19. Other authorized or approved antiviral drugs such as nirmatrelvir/ritonavir
